OBJECTIVE	To determine whether the point-of-care measurement of hemoglobin A ( 1c ) ( HbA ( 1c ) ) and personalized diabetes risk assessments performed during retinal ophthalmologic visits improve glycemic control as assessed by HbA ( 1c ) level .\